A1899812
6-Benzyl-octahydro-pyrrolo[3,4-b]pyridine , 96% , 128740-14-7
| Pack Size | Price | Stock | Quantity |
| 250MG | RMB141.60 | In Stock |
|
| 1G | RMB339.20 | In Stock |
|
| 5G | RMB2399.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Boiling point: | 322℃ |
| Density | 1.049 |
| Flash point: | 131℃ |
| storage temp. | under inert gas (nitrogen or Argon) at 2–8 °C |
| solubility | Chloroform (Slightly), Methanol (Slightly) |
| pka | 10.99±0.20(Predicted) |
| form | Oil |
| color | Clear Light yellow to Light Brown |
| InChI | InChI=1S/C14H20N2/c1-2-5-12(6-3-1)9-16-10-13-7-4-8-15-14(13)11-16/h1-3,5-6,13-15H,4,7-11H2 |
| InChIKey | AFYZAHZKOFBVLE-UHFFFAOYSA-N |
| SMILES | C12CN(CC3=CC=CC=C3)CC1CCCN2 |
Description and Uses
Octahydro-6-(phenylmethyl)-1H-Pyrrolo[3,4-b]pyridine is an intermediate in the synthesis of moxifoxacin (M745000), a fluorinated quinolone antibacterial.
Safety
| Symbol(GHS) | ![]() GHS07 |
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H332-H335 |
| Precautionary statements | P261-P280-P305+P351+P338 |
| Hazard Codes | T |
| Risk Statements | 36/37/38-25 |
| Safety Statements | 26-36/37/39-45 |

![6-Benzyl-octahydro-pyrrolo[3,4-b]pyridine](https://img.chemicalbook.com/CAS/GIF/128740-14-7.gif)

![(4aS,7aS)-1-methyloctahydro-1H-pyrrolo[3,4-b]pyridine](https://img.chemicalbook.com/CAS/20180629/GIF/CB03345928.gif)


![6,7-Dihydro-5H-pyrrolo[3,4-b]pyridine](https://img.chemicalbook.com/CAS/GIF/147739-88-6.gif)
